Lexi-Data, Lexicomp's clinical decision support database is perfect for EMR vendors looking to meet a number of Meaningful Use requirements:
Allows for specific clinical decision support functions, including drug-drug and drug-allergy interaction checking
Has consumer-facing patient education materials
Is compliant with the RxNorm
Include comprehensives reference information for the US including drug generic name, drug brand name, drug classifications, and eventually clinical dosage guidelines for calculating pediatric and adult doses
Lexicomp will be exhibiting at HIMSS 2012 in Las Vegas, from February 20 - 24. Stop by for a visit at Booth #5134 and learn more about the choices you have in drug information databases!
Are you developing EMRs and practice management systemswhere speed to market is critical?One of the modules of such systems is the inclusion of drug information.Since this is neither the expertise of your developers nor your content people,it is important to identify the preferred drug information provider early in the process.Fourcriteria are critical in making this decision.First,quality of information.Second,flexibility of design and APIs.Third,simplicity of data structure.Fourth,and very important,customer support during the development period and after release. More and more EMRs are now using Lexicompdrug information as part of their offering.And there is a reason for that.
Lexi-Data is the foundation of Lexicomp's clinical decision support architecture is quickly becoming the standard for when companies need an up-to-date comprehensive drug database. This product provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, supports Surescripts Certification, Drug Classifications, dose range checking (adult and pediatric), Patient Education, Pediatric and neonatal drug interactions and more.
ePrescribing is offered as a way to prevent medication errors that arise due to difficulties in reading or understanding handwritten prescriptions. ePrescribing could also reduce adverse drug events (ADEs) by making information such as drug interactions and contraindications available to prescribers at the time they are preparing a prescription.
Lexi-Data is the foundation of Lexicomp's clinical decision support architecture is quickly becoming the standard for when companies need an up-to-date comprehensive drug database. This product provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, supports Surescripts Certification, Drug Classifications, dose range checking (adult and pediatric), Patient Education, and more.
Does your EHR meet the certification requirements established by ONC? Lexicomp can help by providing your system key clinical decision support data required for certification. As an integrated component of your EHR, our transactional drug data and reference information support the following Stage 1 meaningful use and certification criteria from ONC's Final Rule.
Lexi-Data is the foundation of Lexicomp's clinical decision support architecture. This product provides clinical decision alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, Drug Classifications, dose range checking (adult and pediatric) and more.
For years, Multum Lexicon was the source for researchers to get drug reference and drug interaction data. But where can researchers now get medication lists, pharmaceutical monographs, drug-drug interactions, drug-allery interactions, and more?
Today, there is an enhanced and updated product built on the foundation of Multum Lexicon. It's Lexicomp's Lexi-Data transactional database. Lexi-Data provides drug names (brand name, generic name, and common abbreviations), therapeutic categories, drug classifications, indications, and standard coding such as NDC, J-Codes, and ICD-9. The data in Lexi-Data has been utilized by many universities and research institutions, including research on pharmaceutical policy and outcomes, aging, and more.
Many EMR and EHR developers wait too long to begin for looking for a supplier of drug data and drug interaction databases. In some respects it seems like a simple chore. There are only a few drug data providers. But the sooner these developers start, the better. Why so?
First, there is a big difference in data structure among the few providers. Lexicomp happens to have a very simple and logical structure, which does solve some headaches if you come in late into the game. But even if you start in a timely way, simpler and more logical is better.
Second, how comprehensive is the data provided? Consider the following needs: drug-drug interaction, drug-allergy interaction, pediatric dosing information, therapeutic dosing information, brand vs generic, Black-Box Warnings, Patient Education Leaflets in multiple languages, drug classifications, and more. There are many things to consider and work on before submitting your development to the certification process. You obviously don't want any surprises.
In the last 24 months more and more EMR developers have selected Lexicomp as their drug information provider. There are many reasons for that. We encourage you to call early in the process.
One difficult aspect of drug nomenclature is the complexity of drug concepts. Clinicians speak fluidly about these concepts, flowing from class-based terminology (penicillins) to individual drugs (penicillin) with ease. But drug classifications are not well standardized, and some systems blend pharmacologic concepts with chemical concepts. For example, consider a system which uses "beta-adrenergic receptor blockers" and "fluoroquinolones". One speaks to the pharmacologic target while the other refers to a shared chemical composition. Clinicians understand and interpret these differences, but electronic applications have more difficulty. RxNorm is an effort to standardize these naming conventions for an individual drug. These concepts are generally included in proprietary vocabularies, but there is little consensus among them. These may complicate efforts to establish comparisons on adverse drug events, allergy, and other comparative features among members of a class. Class level groupings are included in SnoMed and may provide a basis of standardization. For this reason efforts to standardize to a single class nomenclature are important and necessary.
For many years, the primary provider of drug reference and drug interaction information to researchers was Multum's Lexicon product. Today, there is also another product that is built on the foundation of Lexicon. That new product is Lexicomp's Lexi-Data Basic database.
In an earlier post, my colleague Ryan Smith explained how Lexi-Data Basic is now serving the needs of researchers:
"Lexi-Data Basic provides drug information that includes drug names (brand name, generic name, and common abbreviations), therapeutic categories, drug classifications, indications, and standard coding such as NDC, J-Cods, and ICD-9. The Lexi-Data Basic product is powered by the widely known and trusted Multum Lexicon product which has been utilized by hundreds of universities and institutions in the past. Multum is a registered trademark of Cerner Corp."
For more information on Lexi-Data Basic, click the links to fill out the form on this page.
It is estimated that each year some 530,000 adverse drug events take place among Medicare beneficiaries alone because of drugs negatively interacting with other drugs the patient is already taking, or insufficient information about the patient’s medical history. The Institute of Medicine (IOM) reported last year that more than 1.5 million Americans are injured annually by drug errors in hospitals, nursing homes and doctor’s offices. These negative drug events may require costly interventions in order to stabilize the patient, including hospitalization.
Electronic prescribing (eRx) has been recognized as an important step in moving health care from a paper-based legacy to a new electronic platform. The use of ePrescribing has been incentivized by the federal government, specifically via the Centers for Medicare and Medicaid Services (CMS).
Lexi-Data is the foundation of Lexi-Comp's clinical decision support architecture. This product provides patient specific alerts and referential content to support sound treatment decisions in areas such as drug interaction checking (drug-drug and drug-food), drug allergy checking, therapeutic duplication checking, RxNorm Mappings, Drug Classifications, dose range checking (adult and pediatric) and more.
EMR vendors are not the only ones rapidly deploying clinical decision support systems to healthcare providers. Dental professionals are demanding that their practice management systems overcome massive development hurdles in order to comply with Meaningful Use standards.
There is a buzz in the dental technology community about Meaningful Use and incorporating more clinical decision support into the practice management system workflow. If you are searching for the best dental specific drug database to integrate into your dental EMR, turn to Lexicomp. There are very few suppliers of drug data within the dental market and even fewer still that are easy to work with. And if you are looking for an easy-to-use, out-of-the-box ePrescribing tool, trust our partner DoseSpot to deliver the solution. What do all of these companies have in common? They are easy to work with and provide you with the ability to get to the market fast!
Don't wait to the end of your development process to worry about: dose range checking, pediatric dosing, drug calculators, medicine interactions, dosage precautions, clinical guidelines, drug interaction software, duplicate therapy, drug classifications, generic drug names, drug nomenclature and more. These are critical paths for a dental EMR build. But it's not just about the information. It's about who you select as your partner and who has seamless API's which makes your development easier.
You owe it to your product and your customer to make the right choice.
There are many universities and institutions that now require access to an up-to-date standardized drug database which would be used for analytics, claims review / auditing, or research purposes. Many of these universities and/or institutions now have a Pharmaceutical Outcomes and Policy department or Institute on Aging department that are focused on various aspects of research.
One product that has long served the needs of these researchers and univerisities is Multum's Lexicon. Another is Lexi-Data Basic.
Lexi-Data Basic provides drug information that includes drug names (brand name, generic name, and common abbreviations), therapeutic categories, drug classifications, indications, and standard coding such as NDC, J-Cods, and ICD-9. The Lexi-Data Basic product is powered by the widely known and trusted Multum Lexicon product which has been utilized by hundreds of universities and institutions in the past. Multum is a registered trademark of Cerner Corp.
For more information on Lexi-Data Basic, click the links to fill out the form on this page.
Many universities and institutions are now expressing an interest in a standardized drug database. They are in search of a high quality, dependable database that helps their academic department build a reliable model to determine pharmaceutical outcomes. Lexicomp is often the preferred choice.
Whether the researcher is in need of a drug reference database for clinical decision support, for dosage administration, patient education material, drug classifications (brand or generic), adverse drug events, drug-drug interaction, drug-allergy interaction, more and more academics are coming to Lexicomp to secure their drug database information. Check out this page for more information.
There are a high number of companies that are attempting to analyze the usage of a drug products by specific diagnosis, line of therapy, stage of disease, and much more by electronically collecting information through software programs and then performing analytics. These types of companies might be interested in looking at drug and drug combination administered, line of therapy, dose administered, change of therapy reason, and I’m sure that there are many other use cases.
Many of these companies are turning to Lexicomp for core drug nomenclature because Lexicomp's database is up-to-date, highly normalized, flexible classification schemes, and the granular data they need to perform this type of analysis.
Lexi-Data Basic provides drug information that includes drug names (brand name, generic name, route, strength, form, National Drug Code (NDC), etc.), therapeutic categories, drug classifications, pricing, standard or customized disease names and associated ICD-9 codes, and other coding systems such as NDC and J-Codes. This database is compatible with Oracle, SQL Server, MySQL, and Access.
What is holding you back from easy implementation? Perhaps you have a laundry list of items or perhaps money is constraint. Either way, look to Lexicomp for an intuitive database design that will help you seamlessly integrate complex drug databases into your system.
Other items that Lexicomp can help check off your list:
Allows for specific clinical decision support functions, including drug-drug and drug-allergy interaction checking
Has consumer-facing patient education materials
Is compliant with the RxNorm
Include comprehensive reference information for the US including drug generic name, drug brand name, drug classifications, and eventually clinical dosage guidelines for calculating pediatric and adult doses
So look around the market, investigate, but remember that Lexicomp can serve all your needs!
Here are some of the qualifications that drug reference and drug interaction data must meet to qualify:
-- Must allow for specific clinical decision support functions, including drug-drug and drug-allergy interaction checking
-- Must have consumer-facing patient education materials
-- Must be compliant with the RxNorm (a medication list maintained by the National Library of Medicine)
-- Must include comprehensive reference information for the US including drug generic name, drug brand name, drug classifications, and eventually clinical dosage guidelines for calculating pediatric and adult doses
When looking for drug information that meets all these requirement, pick one that will partner with you to meet your needs, whether they be speed to market, budgetary, or customer service.
This is what one of Lexicomp's satisfied customers has to say:
"We spent months researching and investigating the competition. Lexi-Comp business partnering and licensing division gave us the tools we needed to test it in our application to assure our clinicians that we had a reliable and trustworthy source. Their responsiveness to inquiries and requests sold us on a solid partnership we could count on."
According to John at EMR and HIPPA, "My personal projection is that ONC should be really pleased if they achieve 50% EMR adoption by the end of the HITECH act (approximately 5 years). A number of really smart and involved people at HIMSS agreed with me on those numbers."
His other predictions include:
- Small practices have a much lower EMR adoption percentage as compared with large practices
- Specialists have a higher EMR adoption percentage than general medicine doctors
What is the best way to grab those small practices or specialists? Make your EMR the most efficient and best value for them. There are lots of things to consider when building an EMR, but drug information adds value no matter what. Drug information is the foundation upon which safe decisions are made; decisions that involve pediatric dosage, drug interaction, drug classifications, and drug & medicine interactions.
The HITECH Act (commonly known as "Meaningful Use") has some specific requirements for drug reference and drug interaction data which can be used to qualify for incentive money. There aren't many vendors that can provide such specific information, so it's important to shop around to every available seller. Lexicomp and Multum are two vendors that offer qualifying data.
Here are some of the qualifications that drug reference and drug interaction data must meet: -- Must allow for specific clinical decision support functions, including drug-drug and drug-allergy interaction checking -- Must have consumer-facing patient education materials -- Must be compliant with the RxNorm (a medication list maintained by the National Library of Medicine) -- Must include comprehensive reference information for the US including drug generic name, drug brand name, drug classifications, and eventually clinical dosage guidelines for calculating pediatric and adult doses
Both Lexicomp and Multum meet all of these criteria and more. Shopping around to different vendors may give you options that better fit your budget, development environment, support needs, or timeline. But always be sure to ask vendors if their information has been used yet by any EMR, EHR, or HIS vendors who have certified for Meaningful Use under the HITECH Act.
Haven't heard of Brantley Whittington, CEO of the EHR firm Extormity? Then perhaps you've been living under an HIT rock for the past several months. Not to worry, he's made a big splash at HIMSS11 this year and the legend will only continue to grow.
Early Tuesday, at HIMSS11 Extormity, whose tagline is "Expensive, Exasperating, and Exhausting", announced the launch of their newest solution, Manacle: the Shackled Patient Portal. Said Whittington, "If you like tethered portals, you're going to love being shackled."
According to a press release regarding their data security protocols, "Extormity is now storing patient records in the last place anyone would think to look – old 8-track tapes," Whittington explained. "Every night, we download medical data from our servers onto recycled REO Speedwagon, Styx and Chuck Mangione 8-tracks, and we store them in a rusted Trans-Am with T-tops parked in our back parking lot."
Extormity is obviously a fake entity, but they make light of some of the very real pains felt by providers: prohibitive EMR costs, systems that alter workflow, and general turmoil.
In light of all the pains faced by providers trying to implement an EMR or EHR system, isn't it nice to know that there's a REAL company out there offering a REAL product that performs as designed: smoothly, efficiently, and easily? Lexicomp's content integrates seamlessly into various systems offering medicine lists, dosage precautions, pediatric dosage calculations, drug classifications, drug interaction lists, and more.
Take a few minutes to learn more, we promise it will be worth your while. If not, perhaps Manacle is the tool you're seeking after all.
According to a recent article from American Medical News, "Total EMR spending, which is expected to grow from $1.9 billion in 2009 to $3.8 billion by 2015, is about twice the growth rate analysts are seeing over the health information technology market and the general IT market, said Judy Hanover, research director of provider IT strategies for the Framingham, Mass.-based market research company and co-author of the report."
What is the best way to ensure more clients? Make your EMR the most efficient and best value for them. There are lots of things to consider when building an EMR, but drug information adds value no matter what. Drug information is the foundation upon which safe decisions are made; decisions that involve pediatric dosages, drug classifications, drug and medicine interactions, and medicine lists.
If you happen to be in Orlando next week, be sure to stop by booth #6653 to learn more about a great drug database provider.
As a result of a request made by someone who particularly liked one of my posts last month, I am reposting. This year at HIMSS should be pretty interesting, and maybe a bit chaotic and a little unsettling. Meaningful Use was getting bandied about last year, but this year it is real, tangible and around the corner.
Whether you are an EMR vendor, EHR manager, ePrescribing vendor, or someone else in this dynamic and quickly changing business segment, you will want to see what it is going on. One of the areas that is a bit overlooked and undervalued until you have signed a long-term agreement (and it is too late to reconsider) is in the area of drug database information for clinical decision support.
The data is important, but equally important is the relationship with your drug information provider. Once you make your selection, you will be "stuck" with them for a very long time. Make the right choice. Obviously, other areas for evaluation have to do with the level and sophistication of APIs that the vendor has or are under development.
Pediatric dosage calculations, drug interaction software, drug generic name, drug brand name, drug classifications, drug and medicine interactions, medicine lists, clinical guidelines, clinical information systems, and more, are all critical areas for consideration.
At HIMSS 2011 there will also be live demonstrations showing how our drug databases can be implemented and customized to meet the various specific needs of EMR vendors. Stop by and see us if you are a current customer or are looking to implement drug information or clinical decision support into your application, booth #6653.
Lexicomp will be attending HIMSS 2011 in Orlando. This will be a great opportunity for any EMR, Hospital, or Consumer Health Site to visit booth #6653 and learn about our solutions for implementing decision support for drug interactions, duplicate therapy, drug allergies, and dose range checking, as well as drug databases, and patient education information for consumers.
Haven't heard of Brantley Whittington, CEO of the EHR firm Extormity? Then perhaps you've been living under an HIT rock for the past several months. Not to worry, he's made a big splash at HIMSS11 this year and the legend will only continue to grow.
Powered by Compendium